Avatar Medical secures €5 million seed round to democratize access to 3D medical images

February 22, 2024
Avatar Medical announced today the successful closure of a €5 million seed funding round. The investment was led by GO Capital, with support from US-based Acorn Pacific Ventures and Plug and Play as well as Rives Croissance and Cenitz. Fifteen surgeons and radiologists invested in the funding round, showing strong support for this innovative and game-changing solution. This capital infusion signifies a pivotal moment for Avatar Medical. With its transformative technology that instantly converts medical images into patient-specific avatars, the company strives to redefine surgical consultations, while transforming the learning experience for medical students.

Avatar Medical provides a simple, scalable, and real-time solution for surgeons to engage their patients, leveraging the stunning 3D and XR renderings during patient consultations. This revolutionizes shared decision-making between patients and surgeons, and enhances surgical excellence through simpler digital planning, all while providing hospitals with an effective solution to enhance patient satisfaction and reduce patient outmigration. Utilization of Avatar Medical also transforms the way students learn anatomy, pathology, and radiology.

“We are proud of all the achievements, from developing a unique solution to identifying the right go-to-market. This new milestone is very exciting as it gives us the means to launch the commercialization of our FDA-cleared solution in the US, while accelerating the sales to medical schools on both continents”, declared Xavier Wartelle, CEO of Avatar Medical.

With this funding, Avatar Medical will invest in commercialization throughout the US and Europe, while accelerating the development of its AvatarCloud product.

“From our very first meeting with Avatar Medical, we have been deeply impressed by the technology and its team. We are glad to back the company in its exciting journey”, added Frédéric Le Brun, partner at GO Capital.

“Avatar Medical presents a high-potential disruptive solution that Rives Croissance is proud to support”, concluded Bruno Warnet and Benjamin Dejade, partner and analyst at Rives Croissance